BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15679253)

  • 21. Treatment of stage III non-small cell lung cancer with thoracic radiation therapy and simultaneous platinum chemotherapy.
    Bonomi P
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):101-8. PubMed ID: 8052869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Docetaxel in combination with platinums in patients with advanced non-small-cell lung cancer.
    Belani CP
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):42-5. PubMed ID: 9364542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxaliplatin as a radiosensitizing agent in rectal cancer.
    Huerta S; Hrom J
    Anticancer Drugs; 2011 Apr; 22(4):317-23. PubMed ID: 21285866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. J. Jassem on A. Mayer, et al. Primary radiotherapy of stage IIA/B-IIIB cervical carcinoma. A comparison of continuous versus sequential regimens. Strahlenther Onkol 2004;180:209-15 (No. 4).
    Serkies K
    Strahlenther Onkol; 2005 Jan; 181(1):54. PubMed ID: 15660194
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pelvic radiation with concurrent chemotherapy compared with pelvi and para-aortic radiation for high-risk cervical cancer. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. Cisplatin, radiation, and adjuvant hysterectomy for bulky stage Ib cervical carcinoma].
    Nöel G; Mazeron JJ
    Cancer Radiother; 1999; 3(4):345-7. PubMed ID: 10515699
    [No Abstract]   [Full Text] [Related]  

  • 26. Taxanes as first-line therapy for advanced non-small cell lung cancer: a systematic review and practice guideline.
    Chu Q; Vincent M; Logan D; Mackay JA; Evans WK;
    Lung Cancer; 2005 Dec; 50(3):355-74. PubMed ID: 16139391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platinum-based chemotherapy for inoperable non-small cell lung cancer: a real therapeutic progress?
    Buccheri G
    Lung Cancer; 1994 Jul; 11(1-2):115-7. PubMed ID: 7521731
    [No Abstract]   [Full Text] [Related]  

  • 28. Chemoradiation paradigm for the treatment of lung cancer.
    Eberhardt W; Pöttgen C; Stuschke M
    Nat Clin Pract Oncol; 2006 Apr; 3(4):188-99. PubMed ID: 16596143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cancer of the uterine cervix: combination of radiotherapy and cisplatin chemotherapy (chemoradiotherapy) is superior to radiotherapy alone in local advanced stages].
    Mazeron JJ
    Bull Cancer; 1999 Mar; 86(3):247-8. PubMed ID: 10847719
    [No Abstract]   [Full Text] [Related]  

  • 30. A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer.
    Jiang J; Liang X; Zhou X; Huang R; Chu Z
    Lung Cancer; 2007 Sep; 57(3):348-58. PubMed ID: 17485133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cisplatin or carboplatin, that is the question].
    Moncharmont C; Auberdiac P; Mélis A; Afqir S; Pacaut C; Chargari C; Merrouche Y; Magné N
    Bull Cancer; 2011 Feb; 98(2):164-75. PubMed ID: 21382796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defining the role of paclitaxel in lung cancer: summary of recent studies and implications for future directions.
    Bunn PA
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-153-S12-162. PubMed ID: 9331142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving local control in rectal cancer: radiation sensitizers or radiation dose?
    Tepper JE; Wang AZ
    J Clin Oncol; 2010 Apr; 28(10):1623-4. PubMed ID: 20194836
    [No Abstract]   [Full Text] [Related]  

  • 34. Time to add chemotherapy to radiotherapy for cervical cancer.
    Monaghan J
    Lancet; 1999 Apr; 353(9161):1288-9. PubMed ID: 10218522
    [No Abstract]   [Full Text] [Related]  

  • 35. [Analysis of clinical experience in the use of metronidazole as a radiosensitizer of tumors].
    Goldobenko GV; Kherkheulidze ZSh; Shchebetenko IuE; Polotskiĭ BE
    Med Radiol (Mosk); 1983 Jul; 28(7):70-6. PubMed ID: 6348460
    [No Abstract]   [Full Text] [Related]  

  • 36. Anal cancer: an examination of radiotherapy strategies.
    Glynne-Jones R; Lim F
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1290-301. PubMed ID: 21414513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiation dose in non-small cell lung cancer: too much of a good thing?
    Dilling TJ
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):979-82. PubMed ID: 25539360
    [No Abstract]   [Full Text] [Related]  

  • 38. Developments in radiotherapy other than heavy particle beams.
    Fowler JF
    Int J Radiat Oncol Biol Phys; 1977; 3():351-8. PubMed ID: 207661
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of human tumour cell responses to cisplatin and ZD0473 with and without irradiation.
    Raaphorst GP; Yang DP; Li LF; Malone S
    Anticancer Res; 2004; 24(2B):613-8. PubMed ID: 15161002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and side effects of cisplatin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: a systematic review of randomized controlled trials.
    Rajeswaran A; Trojan A; Burnand B; Giannelli M
    Lung Cancer; 2008 Jan; 59(1):1-11. PubMed ID: 17720276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.